SAFETY INFORMATION
Signal word | Warning |
---|---|
Pictogram(s) |
Exclamation Mark Irritant GHS07 |
GHS Hazard Statements |
H302:Acute toxicity,oral H315:Skin corrosion/irritation H319:Serious eye damage/eye irritation H332:Acute toxicity,inhalation H335:Specific target organ toxicity, single exposure;Respiratory tract irritation |
Precautionary Statement Codes |
P261:Avoid breathing dust/fume/gas/mist/vapours/spray. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing. |
COMPUTED DESCRIPTORS
Molecular Weight | 205.68 g/mol |
---|---|
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 2 |
Exact Mass | 205.0869564 g/mol |
Monoisotopic Mass | 205.0869564 g/mol |
Topological Polar Surface Area | 38.3 Ų |
Heavy Atom Count | 13 |
Formal Charge | 0 |
Complexity | 225 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 3 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently-Bonded Unit Count | 2 |
Compound Is Canonicalized | Yes |
PRODUCT INTRODUCTION
Description
Boceprevir is a potent peptidomimetic protease inhibitor that features a unique structure with four distinct moieties: P1, P2, P3, and a Cap. The P1 moiety is a racemic β-aminoamide, which contributes to the compound's overall chirality. The P2 moiety stands out due to its chiral dimethylcyclopropylproline analog, which adopts a constrained conformation through its 3-azabicyclo[3.1.0]hexane structure. The P3 moiety is characterized by (S)-tert-leucine, while the Cap is a tert-butylcarbamoyl group.
RELATED SUPPLIERS
Synaptics Labs Private Limited
1Y
product:(1R,2S,5S)-methyl 6,6-dimethyl-3-aza-bicyclo[3.1.0]hexane-2- carboxylate hydrochloride 565456-77-1 98%
Zenfold Sustainable Technologies (ZST)
1Y
product:565456-77-1 Methyl (1R,2S,5S)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylate hydrochloride 98%
Rushi Pharma
Hyderabad
product:Methyl (1R,2S,5S)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylate hydrochloride